Health-related quality of life in patients with systemic lupus erythematosus and proliferative lupus nephritis

Psychology, Health and Medicine

Volumn 16, Issue 4, 2011, Pages 393-404

  Daleboudt, Gabrille M N ^a   Berger, Stefan P ^a   Broadbent, Elizabeth ^b   Kaptein, Ad A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

cyclophosphamide; disease activity; health related quality of life; proliferative lupus nephritis; SLE

Indexed keywords

AUTOANTIBODY; COMPLEMENT; COMPLEMENT 4 NEPHRITIC FACTOR; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; COMORBIDITY; COMPLEMENT SYSTEM PROTEINS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PATIENTS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 79960671252     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2011.554566     Document Type: Article

References (30)

1. Aaronson, N.K., Muller, M., Cohen, P.D., Essink-Bot, M.L., Fekkes, M., Sanderman, R., Verrips, E. (1998). Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. Journal of Clinical Epidemiology, 51, 1055-1068. (Pubitemid 28527161)
2. Bernatsky, S., Boivin, J.F., Joseph, L., Manzi, S., Ginzler, E., Gladman, D.D., Ramsey-Goldman, R. (2006). Mortality in systemic lupus erythematosus. Arthritis & Rheumatism, 54, 2550-2557. (Pubitemid 44205016)
3. Bernhard, J., Hurny, C., Maibach, R., Herrmann, R., & Laffer, U. (1999). Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Annals of Oncology, 10, 775-782. (Pubitemid 29367993)
4. Bihl, G.R., Petri, M., & Fine, D.M. (2006). Kidney biopsy in lupus nephritis: Look before you leap. Nephrology Dialysis Transplantation, 21, 1749-1752. (Pubitemid 43985694)
5. Bruce, I.N., Mak, V.C., Hallett, D.C., Gladman, D.D., & Urowitz, M.B. (1999). Factors associated with fatigue in patients with systemic lupus erythematosus. Annals of Rheumatic Diseases, 58, 379-381. (Pubitemid 29276997)
6. Buhaescu, I., Covic, A., & Deray, G. (2007). Treatment of proliferative lupus nephritis -a critical approach. Seminars in Arthritis & Rheumatism, 36, 224-237. (Pubitemid 46178520)
7. Contreras, G., Roth, D., Pardo, V., Striker, L.G., & Schultz, D.R. (2002). Lupus nephritis: A clinical review for practicing nephrologists. Clinical Nephrology, 57, 95-107. (Pubitemid 34145192)
8. Coughlin, S.S. (1990). Recall bias in epidemiologic studies. Journal of Clinical Epidemiology, 43(1), 87-91. (Pubitemid 20036970)
9. Goodman, D., Morrissey, S., Graham, D., & Bossingham, D. (2005). The application of cognitive behaviour therapy in altering illness representations of systemic lupus erythematosus. Behaviour Change, 22, 156-171. (Pubitemid 41535987)
10. Grootscholten, C., Ligtenberg, G., Derksen, R.H., Schreurs, K.M., de Glas-Vos, J.W., Hagen, E.C., Berden, J.H. (2003). Health-related quality of life in patients with systemic lupus erythematosus: Development and validation of a lupus specific symptom checklist. Quality of Life Research, 12, 635-644. (Pubitemid 37094027)
11. Grootscholten, C., Snoek, F.J., Bijl, M., van Houwelingen, H.C., Derksen, R.H., & Berden, J.H. (2007). Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/methylprednisolone in a randomized controlled trial. Journal of Rheumatology, 34, 1699-1707. (Pubitemid 47267613)
12. Ito, H., Matsuno, T., Hirayama, T., Tanino, H., & Minami, A. (2007). Health-related quality of life in patients with systemic lupus erythematosus after medium to long-term follow-up of hip arthroplasty. Lupus, 16, 318-323. (Pubitemid 47074832)
13. Jolly, M. (2005). How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? Journal of Rheumatology, 32, 1706-1708. (Pubitemid 41324807)
14. Krupp, L.B., LaRocca, N.G., Muir, J., & Steinberg, A.D. (1990). A study of fatigue in systemic lupus erythematosus. Journal of Rheumatology, 17, 1450-1452.
15. Leong, K.P., Kong, K.O., Thong, B.Y., Koh, E.T., Lian, T.Y., Teh, C.L., Howe, H.S. (2005). Development and preliminary validation of a systemic lupus erythematosusspecific quality-of-life instrument (SLEQOL). Rheumatology, 44, 1267-1276. (Pubitemid 41487960)
16. Levine, L.J., & Safer, M.A. (2002). Sources of bias in memories of emotions. Current Directions in Psychological Science, 11, 169-173.
17. Llewelyn, S., & Kennedy, P. (2003). Handbook of Clinical Health Psychology. West Sussex: John Wiley & Sons Ltd.
18. Manson, J.J., & Rahman, A. (2006). Systemic lupus erythematosus. Orphanet Journal of Rare Diseases, 1, 6.
19. McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I.N., Ahmad, Y., Gordon, C., Teh, L.S. (2007). Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis & Rheumatism, 57, 972-979. (Pubitemid 47237322)
20. McElhone, K., Abbott, J., & Teh, L.S. (2006). A review of health related quality of life in systemic lupus erythematosus. Lupus, 15, 633-643. (Pubitemid 44682824)
21. Petri, M. (2004). Cyclophosphamide: New approaches for systemic lupus erythematosus. Lupus, 13, 366-371. (Pubitemid 38788498)
22. Rees, J., Waldron, D., OBoyle, C., Ewings, P., & MacDonagh, R. (2003). Prospective vs retrospective assessment of lower urinary tract symptoms in patients with advanced prostate cancer: The effect of "response shift". British Journal of Urology International, 92, 703-706. (Pubitemid 37475810)
23. Simard, J.F., & Costenbader, K.H. (2007). What can epidemiology tell us about systemic lupus erythematosus? International Journal of Clinical Practice, 61, 1170-1180. (Pubitemid 46934634)
24. Thumboo, J., & Strand, V. (2007). Health-related quality of life in patients with systemic lupus erythematosus: An update. Annals of Academic Medicine Singapore, 36, 115-122. (Pubitemid 46640263)
25. Tse, K.C., Tang, C.S., Lio, W.I., Lam, M.F., & Chan, T.M. (2006). Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis. Lupus, 15, 371-379. (Pubitemid 44032713)
26. Van der Zee, K.I., & Sanderman, R. (1993). Het meten van de algemene gezondheidstoestand met de RAND-36. Een handleiding/Measuring the general state of health with the RAND-36. A manual. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken.
27. Wang, B., Gladman, D.D., & Urowitz, M.B. (1998). Fatigue in lupus is not correlated with disease activity. Journal of Rheumatology, 25, 892-895. (Pubitemid 28210550)
28. Weening, J.J., DAgati, V.D., Schwartz, M.M., Seshan, S.V., Alpers, C.E., Appel, G.B., Nagata, M. (2004). The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney International, 65, 521-530. (Pubitemid 38130646)
29. West, E., & Jonsson, S.W. (2005). Health-related quality of life in rheumatoid arthritis in Northern Sweden: A comparison between patients with early RA, patients with mediumterm disease and controls, using SF-36. Clinical Rheumatology, 24, 117-122. (Pubitemid 40552962)
30. Wysenbeek, A.J., Leibovici, L., Weinberger, A., & Guedj, D. (1993). Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. British Journal of Rheumatology, 32, 633-635. (Pubitemid 23224947)